Shorts

The FDA’s Approval of High-Dose Nusinersen: What Doctors Should Know

More on misconceptions about CAR-T in neurology

What are some of the misconceptions your colleagues might have about the use of CAR-T in neurology?

The Challenge of T-Cell Therapy Timing

Bad T-cells lead to failed cancer treatments

Why One Target Isn't Enough: The Future of Neuroblastoma Therapy

What should the medical community know about Deramiocel?

Where is neuromuscular medicine heading in the future?

The potential of bringing hemophilia B gene therapy to younger patients

The need for more data for sickle cell gene therapy

Interdisciplinary collaboration in cell and gene therapy

The Reality of Gene Therapy for Sickle Cell Disease

How Families Choose Between SCD Therapies

'Paintable' CAR T-Cells

Can we omit chemotherapy in breast cancer treatment?

Does Immunotherapy Work Better Before Surgery?

The key role of manufacturing in cell therapy success

TIL expansion and more in vivo CAR data in 2026?

What CGT indications do you think will make major progress in 2026?

Thoughts on Cilta-Cel's Boxed Warning

Major FDA Actions in Oncology Cell Therapy in 2025

What buzzwords shaped immunotherapy research and care in 2025?

The TET2 Connection in CAR-Positive Malignancies

Is a $1M Blood Test Worth It for Cancer Trials?

From Pie in the Sky to Curing Leukemia

Watershed Moments That Changed the Field

Harnessing T-Cells for Immune-Based Cancer Treatments

The Role of CD4+ T-Cells in Cancer Therapy

Innovative Treatment Considerations for CAR-T Therapies

The Importance of Nonmyeloablative Chemotherapy to Cell Therapy